🇺🇸 FDA
Patent

US 9579333

Inhibition of HIV infection through chemoprophyalxis

granted A61KA61K31/513A61K31/675

Quick answer

US patent 9579333 (Inhibition of HIV infection through chemoprophyalxis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/513, A61K31/675, A61K31/683, A61K31/7072